Pharmaceutical
| Fri 02 Oct 2026
Munich, Oct. 1 -- Morphic Therapeutic has sought patent for Heterocyclic Compounds as Inhibitors of Alpha-v Beta-1 Integrin. This invention was developed by Babaoglu Kerim, Lin Fu-yang, Hickey Eugene, Buckmelter Alex, Gerasyuto Aleksey, Troast Dawn, Albanese Steve, Dowling James E, Zhong Cheng, Svensson Mats, Bortolato Andrea, L..